ProMIS Neurosciences (PMN) EPS (Basic) (2021 - 2026)
ProMIS Neurosciences' (PMN) quarterly EPS (Basic) came in at -$1.26 in Q1 2026, up 76.04% YoY from -$0.72 in Q1 2025, and up 79.21% on a QoQ basis from -$6.08 in Q4 2025.
ProMIS Neurosciences (PMN) EPS (Basic) (2021 - 2026) Analysis & Trends
ProMIS Neurosciences (PMN) has 6 years of EPS (Basic) data on file, last reported at -$1.26 in Q1 2026.
- Quarterly EPS (Basic) rose 76.04% year-over-year to -$1.26 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.22 (down 828.72% YoY) and the FY2025 annual result came in at -$22.61, down 943.51% from the prior year.
- EPS (Basic) climbed to -$1.26 in Q1 2026, from -$6.08 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $96.16 in Q4 2022 to a low of -$20.7 in Q3 2022.
- A 5-year average of -$0.05 and a median of -$5.93 in 2025 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) surged 938.94% — and 2025, when it plunged 2544.46%.
- Tracing PMN's EPS (Basic) over 5 years: stood at $96.16 in 2022, then slumped by 107.57% to -$7.28 in 2023, then surged by 96.84% to -$0.23 in 2024, then sank by 2544.46% to -$6.08 in 2025, then soared by 79.21% to -$1.26 in 2026.
- The last three EPS (Basic) figures came in at -$1.26 (Q1 2026), -$6.08 (Q4 2025), and -$5.93 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | ProMIS Neurosciences | 132.34 Mn | 78.87 Mn | - | -1.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.28 |
| Mar 31, 2026 | -1.26 |
| Dec 31, 2025 | -6.08 |
| Sep 30, 2025 | -5.93 |
| Jun 30, 2025 | -7.26 |
| Mar 31, 2025 | -5.27 |
| Dec 31, 2024 | -0.23 |
| Sep 30, 2024 | 7.72 |
| Jun 30, 2024 | -3.32 |
| Mar 31, 2024 | -4.65 |
| Dec 31, 2023 | -7.28 |
| Sep 30, 2023 | -4.77 |
| Jun 30, 2023 | -6.74 |
| Mar 31, 2023 | -14.45 |
| Dec 31, 2022 | 96.16 |
| Sep 30, 2022 | -20.70 |
| Jun 30, 2022 | -9.54 |
| Mar 31, 2022 | -7.28 |
| Dec 31, 2021 | 9.26 |
| Sep 30, 2021 | 4.93 |